Diabetes News

Endocrinology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Krone N et al. - Inactivating POR gene mutations are the cause of CAH manifesting with apparent combined CYP17A1–CYP21A2 deficiency. P450 oxidoreductase deficiency (ORD) has a complex phenotype including two unique features not observed in any other CAH variant: skeletal malformations and severe genital ambiguity in both sexes.

Related Articles

Nonclassic Lipoid Congenital Adrenal Hyperplasia Masquerading as Familial Glucocorticoid Deficiency
Journal of Clinical Endocrinology and Metabolism, 10/12/09    Relevance Score: 68%

Mutational Characterization of Steroid 21-Hydroxylase Gene in Portuguese patients with Congenital Adrenal Hyperplasia
Experimental and Clinical Endocrinology & Diabetes, 11/02/09    Relevance Score: 67%

Varied Presentation of Congenital Adrenal Hyperplasia with 21 (OH) Deficiency
Journal of Anaesthesiology Clinical Pharmacology, 10/19/09    Relevance Score: 67%

Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Croatia between 1995 and 2006
Hormone Research, 10/27/09    Relevance Score: 66%

Evaluation of Adrenomedullary Function in Patients with Congenital Adrenal Hyperplasia
Hormone Research, 10/23/09    Relevance Score: 66%

Today in Adrenal Glands...keeping you current

Epidemiology of adrenal crisis in chronic adrenal insufficiency – the need for new prevention strategies
European Journal of Endocrinology, 12/15/09

Diagnosis, management and therapeutic outcome in prepubertal Cushing’s disease
European Journal of Endocrinology, 12/15/09

miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Clinical Cancer Research, 12/15/09